131 related articles for article (PubMed ID: 29989003)
1. Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with
Yoshii Y; Yoshimoto M; Matsumoto H; Tashima H; Iwao Y; Takuwa H; Yoshida E; Wakizaka H; Yamaya T; Zhang MR; Sugyo A; Hanadate S; Tsuji AB; Higashi T
Oncotarget; 2018 Jun; 9(48):28935-28950. PubMed ID: 29989003
[TBL] [Abstract][Full Text] [Related]
2.
Yoshii Y; Matsumoto H; Yoshimoto M; Oe Y; Zhang MR; Nagatsu K; Sugyo A; Tsuji AB; Higashi T
J Nucl Med; 2019 Oct; 60(10):1437-1443. PubMed ID: 30850497
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of vorinostat-sensitized intraperitoneal radioimmunotherapy with
Tachibana T; Yoshii Y; Matsumoto H; Zhang MR; Nagatsu K; Hihara F; Igarashi C; Sugyo A; Tsuji AB; Higashi T
J Cancer Res Ther; 2022; 18(4):907-914. PubMed ID: 36149139
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of PET-guided surgery with 64Cu-labeled cetuximab for resection of intrapancreatic residual tumors in a xenograft mouse model of resectable pancreatic cancer.
Igarashi C; Yoshii Y; Tashima H; Iwao Y; Sakurai K; Hihara F; Tachibana T; Yoshida E; Wakizaka H; Akamatsu G; Yamaya T; Yoshimoto M; Matsumoto H; Zhang MR; Nagatsu K; Sugyo A; Tsuji AB; Higashi T
Nucl Med Commun; 2021 Oct; 42(10):1112-1121. PubMed ID: 34100794
[TBL] [Abstract][Full Text] [Related]
5. Immuno-OpenPET: a novel approach for early diagnosis and image-guided surgery for small resectable pancreatic cancer.
Yoshii Y; Tashima H; Iwao Y; Yoshida E; Wakizaka H; Akamatsu G; Yamaya T; Matsumoto H; Yoshimoto M; Igarashi C; Hihara F; Tachibana T; Zhang MR; Nagatsu K; Sugyo A; Tsuji AB; Higashi T
Sci Rep; 2020 Mar; 10(1):4143. PubMed ID: 32157106
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized
Hihara F; Matsumoto H; Yoshimoto M; Masuko T; Endo Y; Igarashi C; Tachibana T; Shinada M; Zhang MR; Kurosawa G; Sugyo A; Tsuji AB; Higashi T; Kurihara H; Ueno M; Yoshii Y
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628616
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal radioimmunotherapy to treat the early phase of peritoneal dissemination of human colon cancer cells in a murine model.
Kinuya S; Yokoyama K; Fukuoka M; Hiramatsu T; Mori H; Shiba K; Watanabe N; Shuke N; Michigishi T; Tonami N
Nucl Med Commun; 2007 Feb; 28(2):129-33. PubMed ID: 17198354
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of
Matsumoto H; Watabe T; Igarashi C; Tachibana T; Hihara F; Waki A; Zhang MR; Tashima H; Yamaya T; Ooe K; Shimosegawa E; Hatazawa J; Yoshida S; Naito K; Kurihara H; Ueno M; Ito K; Higashi T; Yoshii Y
Pharmaceuticals (Basel); 2021 Sep; 14(10):. PubMed ID: 34681174
[TBL] [Abstract][Full Text] [Related]
9. Copper-67 radioimmunotherapy and growth inhibition by anti-L1-cell adhesion molecule monoclonal antibodies in a therapy model of ovarian cancer metastasis.
Knogler K; Grünberg J; Zimmermann K; Cohrs S; Honer M; Ametamey S; Altevogt P; Fogel M; Schubiger PA; Novak-Hofer I
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):603-11. PubMed ID: 17255283
[TBL] [Abstract][Full Text] [Related]
10. Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.
Gao N; Bozeman EN; Qian W; Wang L; Chen H; Lipowska M; Staley CA; Wang YA; Mao H; Yang L
Theranostics; 2017; 7(6):1689-1704. PubMed ID: 28529645
[TBL] [Abstract][Full Text] [Related]
11. Immuno-PET imaging based radioimmunotherapy in head and neck squamous cell carcinoma model.
Song IH; Noh Y; Kwon J; Jung JH; Lee BC; Kim KI; Lee YJ; Kang JH; Rhee CS; Lee CH; Lee TS; Choi IJ
Oncotarget; 2017 Nov; 8(54):92090-92105. PubMed ID: 29190900
[TBL] [Abstract][Full Text] [Related]
12. Quantitative immuno-SPECT monitoring of pretargeted radioimmunotherapy with a bispecific antibody in an intraperitoneal nude mouse model of human colon cancer.
Schoffelen R; van der Graaf WT; Sharkey RM; Franssen GM; McBride WJ; Chang CH; Bos DL; Goldenberg DM; Oyen WJ; Boerman OC
J Nucl Med; 2012 Dec; 53(12):1926-32. PubMed ID: 23081995
[TBL] [Abstract][Full Text] [Related]
13. Intraperitoneal radioimmunotherapy: Auger electron emitters for solid tumors.
Baranowska-Kortylewicz J
Immunotherapy; 2011 Apr; 3(4):491-4. PubMed ID: 21463190
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
Koppe MJ; Bleichrodt RP; Soede AC; Verhofstad AA; Goldenberg DM; Oyen WJ; Boerman OC
J Nucl Med; 2004 Jul; 45(7):1224-32. PubMed ID: 15235070
[TBL] [Abstract][Full Text] [Related]
15. PET imaging of EGFR expression in nude mice bearing MDA-MB-468, a human breast adenocarcinoma.
Sadri K; Ren Q; Zhang K; Paudyal B; Devadhas D; Rodeck U; Thakur M
Nucl Med Commun; 2011 Jul; 32(7):563-9. PubMed ID: 21572364
[TBL] [Abstract][Full Text] [Related]
16. 177Lu-labeled antibodies for EGFR-targeted SPECT/CT imaging and radioimmunotherapy in a preclinical head and neck carcinoma model.
Liu Z; Ma T; Liu H; Jin Z; Sun X; Zhao H; Shi J; Jia B; Li F; Wang F
Mol Pharm; 2014 Mar; 11(3):800-7. PubMed ID: 24472064
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Safety Evaluation of Intraperitoneally Administered Cu-Conjugated Anti-EGFR Antibody NCAB001 for the Early Diagnosis of Pancreatic Cancer Using PET.
Matsumoto H; Igarashi C; Tachibana T; Hihara F; Shinada M; Waki A; Yoshida S; Naito K; Kurihara H; Ueno M; Ito K; Higashi T; Yoshii Y
Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145676
[TBL] [Abstract][Full Text] [Related]
18. 18F-fluorothymidine PET/CT as an early predictor of tumor response to treatment with cetuximab in human lung cancer xenografts.
Takeuchi S; Zhao S; Kuge Y; Zhao Y; Nishijima K; Hatano T; Shimizu Y; Kinoshita I; Tamaki N; Dosaka-Akita H
Oncol Rep; 2011 Sep; 26(3):725-30. PubMed ID: 21667030
[TBL] [Abstract][Full Text] [Related]
19. PET imaging of insulin-like growth factor type 1 receptor expression with a 64Cu-labeled Affibody molecule.
Su X; Cheng K; Liu Y; Hu X; Meng S; Cheng Z
Amino Acids; 2015 Jul; 47(7):1409-19. PubMed ID: 25854877
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosis.
Koppe MJ; Hendriks T; Boerman OC; Oyen WJ; Bleichrodt RP
J Nucl Med; 2006 Nov; 47(11):1867-74. PubMed ID: 17079821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
